Advent of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis treatment: What consequences on Aspergillus-related diseases? Preliminary insights
- PMID: 36151024
- DOI: 10.1016/j.jcf.2022.09.007
Advent of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis treatment: What consequences on Aspergillus-related diseases? Preliminary insights
Conflict of interest statement
Declaration of Competing Interest None.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical